
Mohamad Raafat Chaaban MD MBA, MSCR
Rhinology & Paranasal Sinus Disease
Associate Professor Vice Chair of Research Cleveland Clinic Lerner College of Medicine at Case Western Reserve University
Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Dr. Chaaban is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mohamad Chaaban is an otolaryngologist in Cleveland, OH at the Cleveland Clinic. He received his medical degree from the American University of Beirut Faculty of Medicine and has been in practice 11 years. He specializes in rhinology & paranasal sinus disease and is experienced in sinusitis, rhinitis, otolaryngic allergy, deviated nasal septum, and rhinology and sinus disease.
Education & Training
Drexel UniversityMS, Clinical Research, 2013 - 2014
George Washington UniversityMBA, Healthcare, 2013 - 2014
George Washington UniversityMBA, HealthCare, 2012 - 2014
University of ChicagoResidency, Otolaryngology - Head and Neck Surgery, 2007 - 2011
Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2006 - 2007
Certifications & Licensure
OH State Medical License 2012 - 2027
TX State Medical License 2015 - 2026
IL State Medical License 2007 - 2017
GA State Medical License 2011 - 2016
AL State Medical License 2011 - 2015
MI State Medical License 2006 - 2007
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- Cochrane Scholars Award American Academy of Otolaryngology-Head and Neck Surgery Foundation, 2018
- Teaching Excellence Award Byron Bailey Surgical Society, 2018
Clinical Trials
- Esmolol vs. Labetalol in Endoscopic Sinus Surgery Start of enrollment: 2017 Mar 01
Publications & Presentations
PubMed
- Correction: Biphenotypic Sinonasal Sarcoma with a Novel PAX3::FOXO6 Fusion: A Case Report and Review of the Literature.Meredith M Nichols, Fatimah Alruwaii, Mohamad R Chaaban, Yu-Wei Cheng, Christopher C Griffith
Head and Neck Pathology. 2026-08-21 - Obesity, Weight Loss, and Rhinology and Allergy.Chase Kahn, Christopher Roxbury, Mohamad R Chaaban
Otolaryngologic Clinics of North America. 2026-07-09 - Obesity and New-Onset Asthma Risk in Chronic Rhinosinusitis: A Population-Based Cohort Study.Austin J Lee, Michael W Liu, Mohamad R Chaaban
Laryngoscope Investigative Otolaryngology. 2026-06-01
Journal Articles
- Epidemiology and trends of anaphylaxis in the United States, 2004-2016Chaaban MR, Warren Z, Baillargeon JG, Baillargeon G, Resto V, Kuo YF, Int Forum Allergy Rhinol., 1/4/2019
- Attitudes of Residents and Program Directors Towards Research in Otolaryngology ResidencyMansi A, Karam WN, Chaaban MR, Ann Otol Rhinol Laryngol., 1/1/2019
- Outcomes and Complications of Balloon and Conventional Functional Endoscopic Sinus SurgeryChaaban MR, Rana N, Baillargeon J, Baillargeon G, Resto V, Kuo YF, Am J Rhinol Allergy, 1/1/2018
Books/Book Chapters
Abstracts/Posters
- Mucosal Bleeding and Intraoperative Visibility during Endoscopic Sinus Surgery: A Blinded Randomized Controlled Trial with Labetalol and Esmolol.Chaaban MR, Triological Society 121st Annual Meeting at COSM, National Harbor, MD, 1/20/2018
- Epidemiology and Trends of Anaphylaxis in the United States, 2004-2016.Chaaban MR, American Academy of Otolaryngic Allergy Annual Meeting, Atlanta, GA, 1/7/2018
- "Controversies in Allergy Testing and Immunotherapy: Challenging Traditional Practice".Chaaban MR, American Rhinologic Society Summer Sinus Symposium, 1/1/2018
Press Mentions
Acid-Suppressive Medication and Antimicrobial Use in Infancy Associated With Food Allergy and AnaphylaxisFebruary 7th, 2024
Study Reveals Weight Loss Medications May Improve Outcomes for Chronic Sinus Disease PatientsJanuary 23rd, 2026
Ozempic May Improve Outcomes from Sinus SurgeryJanuary 30th, 2026
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









